We serve Chemical Name:mdbdjwqgokyjow-uhfffaoysa CAS:120079-42-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:mdbdjwqgokyjow-uhfffaoysa
CAS.NO:120079-42-7
Synonyms:5,6,7,8-Tetrahydro-10H-pyrido[1,2-a]thieno[3,2-d]pyrimidin-10-one;InChI=1/C10H10N2OS/c13-10-9-7(4-6-14-9)11-8-3-1-2-5-12(8)10/h4,6H,1-3,5H2
Molecular Formula:C10H10N2OS
Molecular Weight:206.26400
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:371.839ºC at 760 mmHg
Density:1.524g/cm3
Index of Refraction:1.778
PSA:63.13000
Exact Mass:206.05100
LogP:1.79430
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5,6,7,8-Tetrahydro-10H-pyrido[1,2-a]thieno[3,2-d]pyrimidin-10-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,InChI=1/C10H10N2OS/c13-10-9-7(4-6-14-9)11-8-3-1-2-5-12(8)10/h4,6H,1-3,5H2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,InChI=1/C10H10N2OS/c13-10-9-7(4-6-14-9)11-8-3-1-2-5-12(8)10/h4,6H,1-3,5H2 Use and application,InChI=1/C10H10N2OS/c13-10-9-7(4-6-14-9)11-8-3-1-2-5-12(8)10/h4,6H,1-3,5H2 technical grade,usp/ep/jp grade.
Related News: Inceptua has global operations with local offices across Europe, USA, and Asia mdbdjwqgokyjow-uhfffaoysa manufacturer ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. mdbdjwqgokyjow-uhfffaoysa supplier ��Inceptua Medicines Access is delighted to be selected as Onconova��s partner for the Pre-approval Access Program for rigosertib. mdbdjwqgokyjow-uhfffaoysa vendor Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday. mdbdjwqgokyjow-uhfffaoysa factory Inceptua has global operations with local offices across Europe, USA, and Asia
